Medical Health & Life Science Research News

Growth prospects of the Global viscosupplementation market from 2016 to 2020 scrutinized in new research

Growth prospects of the Global viscosupplementation market from 2016 to 2020 scrutinized in new research

Global Viscosupplementation market is expected to grow at a CAGR of 6.23% during the period 2016-2020.

Report Global Viscosupplementation Market 2016-2020 is a new market research publication announced by Reportstack. 

Report Outline: Viscosupplementation is a minimally invasive treatment for knee osteoarthritis. It involves the injection of hyaluronic acid into a knee joint to assist the viscous properties of synovial fluid.

The procedure increases the joint’s functioning and reduces pain.

- Advertisement -
- Membership expired -
Intra-articular viscosupplementation with hyaluronic acid is gaining acceptance as it is a non-invasive procedure compared to knee replacement.

It is categorized into three product segments –– single-injection cycle, three-injection cycle, and five-injection cycle.

For detailed report with TOC, please click here ​Global Viscosupplementation Market 2016-2020 Make an Inquiry about this news

Market Growth: The global Viscosupplementation market is expected to grow at a CAGR of 6.23% during the period 2016-2020.

Key vendors 
• Sanofi
• Anika Therapeutics
• Seikagaku
• Fidia Farmaceutici
• Ferring Pharmaceuticals

Other prominent vendors 
• Allergan
• Contipro Biotech
• DePuy Synthes
• F. Hoffmann-La Roche
• Galderma
• HTL Biotechnology
• Hyaltech
• Expanscience Laboratoires
• Lifecore Biomedical
• Lipo Chemicals
• Merz Aesthetics
• Mylan
• Nordic Drugs
• Shandong Freda Biochem
• Shanghai Jingfeng Pharmaceutical
• Smith & Nephew
• TEIJIN PHARMA

• TRB Chemedica International

Regions Covered: 

• Americas
• APAC
• EMEA

Companies Mentioned

Lear Corporation, Johnson Controls, Grammer AG.

For more information:

Make an Inquiry about this report HERE!
  • www.reportstack.com/product/307728…et-2016-2020.html
  • www.reportstack.com